Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

Notice to the media - COVID-19 Update (March 23, 2021) - Ministers and Government of Canada officials to hold a news conference on coronavirus disease


OTTAWA, ON, March 23, 2021 /CNW/ - Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

Date
March 23, 2021

Time
12:00 PM (EDT)

Location

The news conference will be held virtually. Journalists who wish to ask questions can do so by teleconference.

Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003
Passcode: 1622050#

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: